Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. TG Therapeutics Inc shares valued at $162,850 were sold by Echelard Yann on Nov 24 ’25. At $32.57 per share, Echelard Yann sold 5,000 shares. The insider’s holdings dropped to 223,816 shares worth approximately $7.02 million following the completion of this transaction.
Also, Echelard Yann purchased 5,000 shares, netting a total of over 162,850 in proceeds.
Before that, Lonial Sagar had sold 20,852 shares from its account. In a trade valued at $672,268, the Director traded TG Therapeutics Inc shares for $32.24 each. Upon closing the transaction, the insider’s holdings decreased to 20,852 shares, worth approximately $2.95 million.
As of October 29, 2024, TD Cowen has initiated its “Buy” rating for TGTX. Earlier on August 02, 2023, Goldman upgraded its rating. Their new recommendation was “a Neutral” for TGTX stock which previously was a “a Sell”.
Analyzing TGTX Stock Performance
On last trading session, TG Therapeutics Inc [NASDAQ: TGTX] plunged -0.73% to $31.38. The stock’s lowest price that day was $31.355, but it reached a high of $32.26 in the same session. During the last five days, there has been a drop of approximately -6.08%. Over the course of the year, TG Therapeutics Inc shares have dropped approximately -10.57%. Shares of the company reached a 52-week high of $46.48 on 05/01/25 and a 52-week low of $25.28 on 08/11/25.
Support And Resistance Levels for TG Therapeutics Inc (TGTX)
According to the 24-hour chart, there is a support level at 31.07, which, if violated, would cause prices to drop to 30.75. In the upper region, resistance lies at 31.98. The next price resistance is at 32.57. RSI (Relative Strength Index) is 44.93 on the 14-day chart, showing neutral technical sentiment.
Is TG Therapeutics Inc subject to short interest?
Stocks of TG Therapeutics Inc saw a sharp rise in short interest on 2025-11-14 jumping by 1.41 million shares to 25.22 million. Data from Yahoo Finance shows that the short interest on 2025-10-15 was 23.81 million shares. A jump of 5.61% in short interest reflects a negative sentiment towards the stock. Despite the fact that short shares comprise just 12.74 of the overall float, the days-to-cover ratio (short ratio) jumped to 12.74.
Which companies own the most shares of TG Therapeutics Inc (TGTX)?
In terms of TG Therapeutics Inc share price expectations, FactSet research, analysts set an average price target of 60 in the next 12 months, up nearly 89.81% from the previous closing price of $31.61. Analysts anticipate TG Therapeutics Inc stock to reach 60 by 2025, with the lowest price target being 60. In spite of this, 6 analysts ranked TG Therapeutics Inc stock as Buy at the end of 2025. On June 26, 2023, Jefferies assigned a price target of “a Buy” to the stock and resumed coverage with a $40.
